Rigel Pharmaceutical Inc. diskutieren
Rigel Pharmaceutical Inc.
WKN: 766093 / Symbol: RIGL / Name: Rigel Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
0,74 €
-0,51 %
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $57.00 price target on the stock.
Ratings data for RIGL provided by MarketBeat
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at Citigroup Inc. from $49.00 to $55.00. They now have a "buy" rating on the stock.
Ratings data for RIGL provided by MarketBeat
Rigel Pharmaceuticals (NASDAQ:RIGL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $57.00 price target on the stock.
Ratings data for RIGL provided by MarketBeat
Rigel Pharmaceuticals (NASDAQ:RIGL) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $42.00 price target on the stock.
Ratings data for RIGL provided by MarketBeat
Neueste Beiträge
HC_Wainwright in Biocryst Pharmaceuticals diskutieren